Susquehanna International Group
ENTX icon

Susquehanna International Group’s Entera Bio ENTX Stock Holding History

Susquehanna International Group’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,100
Closed -$40.5K – 12649
2025
Q3 		$40.5K Buy
+21,100
New +$40.4K ﹤0.01% 11917
2025
Q1 		– Sell
-24,500
Closed -$51.2K – 12713
2024
Q4 		$51.2K Buy
+24,500
New +$45.7K ﹤0.01% 11666
2023
Q1 		– Sell
-51,300
Closed -$37.4K – 12768
2022
Q4 		$37.4K Sell
51,300
-1,400
-3% -$1.01K ﹤0.01% 11542
2022
Q3 		$55K Sell
52,700
-900
-2% -$1.36K ﹤0.01% 12132
2022
Q2 		$71K Sell
53,600
-2,400
-4% -$5.33K ﹤0.01% 11753
2022
Q1 		$160K Sell
56,000
-9,100
-14% -$21.8K ﹤0.01% 11491
2021
Q4 		$184K Sell
65,100
-24,800
-28% -$92.9K ﹤0.01% 11545
2021
Q3 		$423K Sell
89,900
-62,000
-41% -$318K ﹤0.01% 9804
2021
Q2 		$908K Buy
+151,900
New +$562K ﹤0.01% 8031

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Susquehanna International Group's ENTX Position: Q1 2026 in Review

Susquehanna International Group sold out of Entera Bio (ENTX) in Q1 2026, closing a stake of 64,910 shares — an estimated $126K sold.

Susquehanna International Group first reported a position in ENTX in Q2 2021 and held it in 9 quarters. The position peaked at $399K in Q2 2021. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

  • Susquehanna International Group reported no remaining Entera Bio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 64,910 Entera Bio shares in Q1 2026, an estimated $126K.
  • Susquehanna International Group first reported a position in Entera Bio in Q2 2021 and held it in 9 quarters.
  • Susquehanna International Group's Entera Bio position peaked at $399K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.